UNITY color transp BG.jpg
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
April 21, 2021 08:00 ET | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases...
UNITY color transp BG.jpg
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates
March 23, 2021 16:01 ET | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of...
UNITY color transp BG.jpg
UNITY Biotechnology to Participate in Upcoming March Investor Conferences
February 26, 2021 16:05 ET | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of...
UNITY color transp BG.jpg
UNITY Biotechnology Reports Granting of New Employment Inducement Awards
February 24, 2021 08:00 ET | Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of...
UNITY color transp BG.jpg
Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease
February 08, 2021 08:00 ET | Unity Biotechnology, Inc.
Study shows that senescent cells accumulate in the eye of patients with diabetic retinopathy, and elimination of these cells in preclinical models ameliorates disease Researchers at UNITY...
UNITY color transp BG.jpg
UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor
February 01, 2021 08:00 ET | Unity Biotechnology, Inc.
Mike Sapieha brings world-class expertise in aging-related ophthalmologic and neurologic diseases UNITY also names Jason Damiano, Ph.D., as vice president of translational biology and Nathan Guz,...
UNITY color transp BG.jpg
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
September 15, 2020 08:00 ET | Unity Biotechnology, Inc.
- Corporate restructuring to extend cash runway through mid-2022 and key milestones - - UBX1325 to enter clinical development in patients with diabetic macular edema - SAN FRANCISCO, Calif., Sept. ...
UNITY color transp BG.jpg
UNITY Biotechnology to Participate in Upcoming September Investor Conferences
September 04, 2020 08:00 ET | Unity Biotechnology, Inc.
SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY color transp BG.jpg
UNITY Biotechnology Announces Appointment of Lynne Sullivan as Chief Financial Officer
August 31, 2020 16:05 ET | Unity Biotechnology, Inc.
SAN FRANCISCO, Aug. 31, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing...
UNITY color transp BG.jpg
UNITY Biotechnology Announces 12-week data from UBX0101 Phase 2 Clinical Study in Patients with Painful Osteoarthritis of the Knee
August 17, 2020 07:00 ET | Unity Biotechnology, Inc.
UBX0101 failed to meet 12-week primary endpointGuidance for UNITY’s Bcl-xL inhibitor UBX1325 in retinal disease remains unchangedUNITY to focus senescence programs on ophthalmologic and neurologic...